Affinity proteins and their generation

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Chemical Technology & Biotechnology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Chemistry

• Identifiers
  DOI 10.1002/JCTB.3929
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Mixed oligonucleotides for random mutagenesis: best way of making them.

  2012cited by this paper
• Ribosome display: a perspective.

  2012cited by this paper
• Rapid selection of high-affinity binders using ribosome display.

  2012cited by this paper
• Affinity recovery of eight HER2-binding affibody variants using an anti-idiotypic affibody molecule as capture ligand.

  2011cited by this paper
• Bacterial display in combinatorial protein engineering

  2011cited by this paper
• DARPins and other repeat protein scaffolds: advances in engineering and applications.

  2011cited by this paper
• Comparative biodistribution of imaging agents for in vivo molecular profiling of disseminated prostate cancer in mice bearing prostate cancer xenografts: focus on 111In- and 125I-labeled anti-HER2 humanized monoclonal trastuzumab and ABY-025 affibody.

  2011cited by this paper
• Non-immunoglobulin based protein scaffolds.

  2011cited by this paper
• Combining phage and staphylococcal surface display for generation of ErbB3-specific Affibody molecules.

  2011cited by this paper
• Engineering Bispecificity into a Single Albumin-Binding Domain

  2011cited by this paper
• Random mutagenesis by error-prone PCR.

  2010cited by this paper
• Staphylococcal surface display in combinatorial protein engineering and epitope mapping of antibodies.

  2010cited by this paper
• Molecular Imaging of HER2-Expressing Malignant Tumors in Breast Cancer Patients Using Synthetic 111In- or 68Ga-Labeled Affibody Molecules

  2010cited by this paper
• Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications

  2010cited by this paper
• Exploring epitopes of antibodies toward the human tryptophanyl-tRNA synthetase.

  2010cited by this paper
• Affinity maturation of a TNFα‐binding Affibody molecule by Darwinian survival selection

  2010cited by this paper
• Adnectins: engineered target-binding protein therapeutics

  2010cited by this paper
• Selection of TNF-alpha binding affibody molecules using a beta-lactamase protein fragment complementation assay.

  2009cited by this paper
• Biological diversity and therapeutic potential of natural and engineered cystine knot miniproteins.

  2009cited by this paper
• Antibody library selection by the {beta}-lactamase protein fragment complementation assay.

  2009cited by this paper
• Protein complementation assays: Approaches for the in vivo analysis of protein interactions

  2009cited by this paper
• Engineering the binding properties of the T cell receptor:peptide:MHC ternary complex that governs T cell activity.

  2009cited by this paper
• Engineered protein scaffolds as next-generation antibody therapeutics.

  2009cited by this paper
• Yeast Two-Hybrid, a Powerful Tool for Systems Biology

  2009cited by this paper
• Genome Analysis of the Meat Starter Culture Bacterium Staphylococcus carnosus TM300

  2008cited by this paper
• A novel affinity protein selection system based on staphylococcal cell surface display and flow cytometry.

  2008cited by this paper
• Construction and characterization of a fully active PXR/SRC-1 tethered protein with increased stability W.Wang, W.W.Prosise, J.Chen, S.Shane Taremi, H.V.Le, V.Madison, X.Cui, A.Thomas, K.-C.Cheng and C.A.Lesburg 425 Directed evolution of a biterminal bacterial display scaffold enhances the display o

  2008cited by this paper
• Epitope mapping of antibodies using bacterial surface display

  2008cited by this paper
• Alternative binding proteins: Anticalins – harnessing the structural plasticity of the lipocalin ligand pocket to engineer novel binding activities

  2008cited by this paper
• Simplified characterization through site-specific protease-mediated release of affinity proteins selected by staphylococcal display.

  2008cited by this paper
• Picomolar affinity fibronectin domains engineered utilizing loop length diversity, recursive mutagenesis, and loop shuffling.

  2008cited by this paper
• Ecallantide (DX-88), a plasma kallikrein inhibitor for the treatment of hereditary angioedema and the prevention of blood loss in on-pump cardiothoracic surgery

  2008cited by this paper
• Selection and characterization of Affibody ligands binding to Alzheimer amyloid β peptides

  2007cited by this paper
• Protein A chromatography for antibody purification.

  2007cited by this paper
• Phage display selection of Affibody molecules with specific binding to the extracellular domain of the epidermal growth factor receptor.

  2007cited by this paper
• Protein engineering with bacterial display.

  2007cited by this paper
• Selection of single domain binding proteins by covalent DNA display.

  2007cited by this paper
• Alternative non-antibody scaffolds for molecular recognition.

  2007cited by this paper
• Isolation of engineered, full-length antibodies from libraries expressed in Escherichia coli

  2007cited by this paper
• Improvement of a recombinant anti-monkey anti-CD3 diphtheria toxin based immunotoxin by yeast display affinity maturation of the scFv.

  2007cited by this paper
• Optimization of electroporation‐mediated transformation: Staphylococcus carnosus as model organism

  2007cited by this paper
• Evolution of an interloop disulfide bond in high-affinity antibody mimics based on fibronectin type III domain and selected by yeast surface display: molecular convergence with single-domain camelid and shark antibodies.

  2007cited by this paper
• Yeast surface display for protein engineering and characterization

  2007cited by this paper
• Antibody therapeutics:

  2007cited by this paper
• Evaluation of Staphylococcal Cell Surface Display and Flow Cytometry for Postselectional Characterization of Affinity Proteins in Combinatorial Protein Engineering Applications

  2007cited by this paper
• Properties, production, and applications of camelid single-domain antibody fragments

  2007cited by this paper
• Affibody molecules: potential for in vivo imaging of molecular targets for cancer therapy

  2007cited by this paper
• Progress in computational protein design.

  2007cited by this paper
• Neutralization of staphylococcal enterotoxin B by soluble, high-affinity receptor antagonists

  2007cited by this paper
• Affilin-novel binding molecules based on human γ-B-crystallin, an all β-sheet protein

  2007cited by this paper
• Direct selection of antibodies from complex libraries with the protein fragment complementation assay.

  2006cited by this paper
• Tumor imaging using a picomolar affinity HER2 binding affibody molecule.

  2006cited by this paper
• Construction and characterization of a pseudo-immune human antibody library using yeast surface display.

  2006cited by this paper
• Directed evolution to probe protein allostery and integrin I domains of 200,000-fold higher affinity.

  2006cited by this paper
• Signal sequences directing cotranslational translocation expand the range of proteins amenable to phage display

  2006cited by this paper
• A new generation of protein display scaffolds for molecular recognition

  2006cited by this paper
• All individual domains of staphylococcal protein A show Fab binding.

  2006cited by this paper
• Bacterial display using circularly permuted outer membrane protein OmpX yields high affinity peptide ligands

  2006cited by this paper
• Multivalent avimer proteins evolved by exon shuffling of a family of human receptor domains

  2005cited by this paper
• Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity

  2005cited by this paper
• Engineered antibody fragments and the rise of single domains

  2005cited by this paper
• Nucleic Acids Research Complete nucleotide sequence of the Upase gene from Staphylococcus hyicus cloned in Staphylococcus carnosus

  2005cited by this paper
• Fine affinity discrimination by normalized fluorescence activated cell sorting in staphylococcal surface display.

  2005cited by this paper
• Molecular evolution of antibody affinity for sensitive detection of botulinum neurotoxin type A.

  2005cited by this paper
• Structure of a shark IgNAR antibody variable domain and modeling of an early‐developmental isotype

  2005cited by this paper
• Selecting and screening recombinant antibody libraries

  2005cited by this paper
• Lipocalins in drug discovery: from natural ligand-binding proteins to "anticalins".

  2005cited by this paper
• Engineering novel binding proteins from nonimmunoglobulin domains

  2005cited by this paper
• Evolving strategies for enzyme engineering.

  2005cited by this paper
• Class II-restricted T cell receptor engineered in vitro for higher affinity retains peptide specificity and function.

  2005cited by this paper
• Arming antibodies: prospects and challenges for immunoconjugates

  2005cited by this paper
• Potent inhibition of huntingtin aggregation and cytotoxicity by a disulfide bond-free single-domain intracellular antibody.

  2004cited by this paper
• Crystal structure of HEL4, a soluble, refoldable human V(H) single domain with a germ-line scaffold.

  2004cited by this paper
• Yeast mating for combinatorial Fab library generation and surface display

  2004cited by this paper
• Binding proteins from alternative scaffolds.

  2004cited by this paper
• Selection and characterization of HER2/neu-binding affibody ligands.

  2004cited by this paper
• Chemical and biochemical strategies for the randomization of protein encoding DNA sequences: library construction methods for directed evolution.

  2004cited by this paper
• In-vitro protein evolution by ribosome display and mRNA display.

  2004cited by this paper
• Anchored periplasmic expression, a versatile technology for the isolation of high-affinity antibodies from Escherichia coli-expressed libraries.

  2004cited by this paper
• Novel methods for directed evolution of enzymes: quality, not quantity.

  2004cited by this paper
• Complement function in mAb-mediated cancer immunotherapy.

  2004cited by this paper
• Antibodies from phage antibody libraries.

  2004cited by this paper
• Combinatorial codon-based amino acid substitutions.

  2004cited by this paper
• Domain antibodies: proteins for therapy.

  2003cited by this paper
• Affinity maturation of Fab antibody fragments by fluorescent‐activated cell sorting of yeast‐displayed libraries

  2003cited by this paper
• A novel strategy to design binding molecules harnessing the modular nature of repeat proteins

  2003cited by this paper
• Fluorescence-Activated Cell Sorting of Specific Affibody-Displaying Staphylococci

  2003cited by this paper
• Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library

  2003cited by this paper
• Theoretical analysis of antibody targeting of tumor spheroids: importance of dosage for penetration, and affinity for retention.

  2003cited by this paper
• A comparison of directed evolution approaches using the beta-glucuronidase model system.

  2003cited by this paper
• Directed evolution of high-affinity antibody mimics using mRNA display.

  2002cited by this paper
• Protein–protein interactions monitored in mammalian cells via complementation of β-lactamase enzyme fragments

  2002cited by this paper
• General expression vectors for Staphylococcus carnosus enabled efficient production of the outer membrane protein A of Klebsiella pneumoniae.

  2002cited by this paper
• β-Lactamase protein fragment complementation assays as in vivo and in vitro sensors of protein–protein interactions

  2002cited by this paper
• Vector engineering to improve a staphylococcal surface display system.

  2002cited by this paper
• Engineering of staphylococcal surfaces for biotechnological applications.

  2002cited by this paper
• Generation of Metal-Binding Staphylococci through Surface Display of Combinatorially Engineered Cellulose-Binding Domains

  2001cited by this paper
• Model systems: Studying molecular recognition using bacterial n-hybrid systems.

  2001cited by this paper
• Directed immobilization of recombinant staphylococci on cotton fibers by functional display of a fungal cellulose-binding domain.

  2001cited by this paper
• A heterodimeric coiled-coil peptide pair selected in vivo from a designed library-versus-library ensemble.

  2000cited by this paper

• Protein L—More Than Just an Affinity Ligand

  2021cites this paper
• Evaluating the Therapeutic Efficacy of Mono- and Bivalent Affibody-Based Fusion Proteins Targeting HER3 in a Pancreatic Cancer Xenograft Model

  2020cites this paper
• Calcium-dependent affinity ligands for protein purification

  2020cites this paper
• Molecular features of steroid-binding antidins and their use for assaying serum progesterone

  2019cites this paper
• Fusion with an albumin‐binding domain improves pharmacokinetics of an αvβ3‐integrin binding fibronectin scaffold protein

  2019cites this paper
• Engineering and characterisation of anti-progesterone OBodies

  2018cites this paper
• Generation and engineering of ABD-derived affinity proteins for clinical applications

  2018cites this paper
• Construction of Artificial TNF-Binding Proteins Based on the 10 th Human Fibronectin Type III Domain Using Bacterial Display CONSTRUCTION OF TNF-BINDING PROTEINS

  2018cites this paper
• Construction of Artificial TNF-Binding Proteins Based on the 10th Human Fibronectin Type III Domain Using Bacterial Display

  2018cites this paper
• Autotransporter-Mediated Display of a Naïve Affibody Library on the Outer Membrane of Escherichia coli.

  2018cites this paper
• Fusion with the cold-active esterase facilitates autotransporter-based surface display of the 10th human fibronectin domain in Escherichia coli

  2017cites this paper
• Cell line and protein engineering tools for production and characterization of biologics

  2017cites this paper
• Targeting Ability of Affibody-Functionalized Particles Is Enhanced by Albumin but Inhibited by Serum Coronas.

  2015cites this paper
• Bacteria-based methods for engineering and characterization of proteases and affinity proteins

  2015cites this paper
• Towards Personalized Cancer Therapy : New Diagnostic Biomarkers and Radiosensitization Strategies

  2015influential citation
• Preparation and characterization of novel IgG affinity resin coupling anti-Fc camelid single-domain antibodies.

  2015cites this paper
• Engineering of Affibody molecules targeting the Alzheimer’s-related amyloid β peptide

  2015cites this paper
• Man-made antibodies and immunoconjugates with desired properties: function optimization using structural engineering

  2015cites this paper
• Biosensor Enhancement Using Grooved Micromixers: Part II, Experimental Studies.

  2015cites this paper
• Alternative Protein Scaffolds for Molecular Imaging and Therapy

  2014cites this paper
• Perspectives in glycomics and lectin engineering.

  2014cites this paper
• A new prodrug form of Affibody molecules (pro-Affibody) is selectively activated by cancer-associated proteases

  2014cites this paper
• Generation and characterization of Affibody molecules targeting HER3

  2013influential citation
• Construction of proteins with molecular recognition capabilities using α3β3 de novo protein scaffolds.

  2013cites this paper
• Engineering of Affibody molecules for Radionuclide Molecular Imaging and Intracellular Targeting

  2013cites this paper
• An albumin-binding domain as a scaffold for bispecific affinity proteins

  2012cites this paper